Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 1

3(50.0%)

Phase 4

1(16.7%)

N/A

1(16.7%)

Phase 2

1(16.7%)

6Total

Phase 1(3)

Phase 4(1)

N/A(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01223066Withdrawn

Macrolane Prospective Survey

Role: collaborator

NCT01750112Not ApplicableCompleted

Treatment of Pectus Excavatum Deformity Using Macrolane Filler

Role: collaborator

NCT01987804Phase 2Completed

Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women

Role: collaborator

NCT01619423Phase 1Completed

A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer

Role: collaborator

NCT02482324Phase 1Completed

Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers

Role: collaborator

NCT01265992Completed

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Role: collaborator

NCT00808509Phase 4Completed

A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission

Role: collaborator

NCT01578070Phase 1Completed

Single-center Study Evaluating the Safety and Efficacy of Viscogel® as Adjuvant in Act-HIB® Vaccine

Role: collaborator

All 8 trials loaded